Guest guest Posted March 18, 2008 Report Share Posted March 18, 2008 Now we're talking! I liked this part: "or interim Phase I data delivered using Inovio's DNA delivery systems have shown significantly enhanced antibody and T-cell immune responses relative to plasmid DNA delivered by other methods, suggesting the potential to provide better preventive or therapeutic effects against complex infectious diseases and cancers. Wow - this could change everything - and they're in Phase 1? A lot of the supplements that I take are for "changes on the cellular level" and repair of the DNA - so this stuff sounds so promising!!!!!!!! Thanks for posting this, Chris March 17, 2008 10:01 AM Eastern Daylight Time PermalinkTo save a permanent link to this news, right-click the dateline (Ctl-click on a Mac) to copy the link. Hepatitis C Virus DNA Vaccine Shows Safety When Delivered by Inovio Biomedical’s Electroporation Delivery System in Phase I/II Clinical Study at Karolinska University Hospital SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced today that its partner, Tripep AB of Sweden, has reported preliminary results from the first patient to complete treatment with Tripep’s therapeutic hepatitis C virus (HCV) vaccine, ChronVac-C®, which was delivered using Inovio’s electroporation-based DNA delivery system. In this phase I/II clinical study, the treatment has so far been safe and tolerable. Create a Home Theater Like the Pros. Watch the video on AOL Home. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.